UnitedHealthcare
Seebri Neohaler (glycopyrrolate)
Drugs for the Lungs : Drugs for Asthma/COPD
  • Prior Authorization Required
  • COPD (oral):
    Duration: 12 Month(s)
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    COPD associated with chronic bronchitis: No
    History of COPD exacerbation: No
    Documented Diagnosis: Yes

  • Step Therapy: COPD (oral):
    1 of [Spiriva Respimat, Spiriva With HandiHaler] and Incruse Ellipta